Device / Technology News

RSS

Phase 1 trial of Cerus' INTERCEPT red blood system meets primary endpoint

Cerus Corporation announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. The INTERCEPT red blood cell system is a pathogen inactivation treatment the company is developing to protect against transmission of infectious diseases through red blood cell transfusions. An estimated 70 million units of red blood cells are transfused worldwide each year.

9 Feb 2010

BD recalls certain lots of BD Q-Syte Luer Access Devices and BD Nexiva Closed IV Catheter Systems

BD (Becton, Dickinson and Company) has voluntarily executed a product recall of certain lots of BD Q-Syte™ Luer Access Devices and BD Nexiva™ Closed IV Catheter Systems. Use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death. This field corrective action included notification to customers worldwide by letter. Neither the costs anticipated with the recall, nor the impact on BD's business, are expected to be material.

From BD (Becton, Dickinson and Company) 9 Feb 2010

Emerging Healthcare Solutions issues Term Sheet review to ThromboVision

Emerging Healthcare Solutions, Inc. announced today that management has formally delivered an actionable Term Sheet to ThromboVision for review and that follow up communications have been very favorable.

9 Feb 2010

Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovarian cancer

A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States. Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or progression of epithelial ovarian cancer. If approved, this important immunoassay would be the first automated HE4 test available in the United States.

9 Feb 2010

BioElectronics and SAY-GIN sign agreement to sell ActiPatch and Allay products in Turkey

BioElectronics Corp., the maker of inexpensive, disposable, drug-free anti-inflammatory devices, today announced it has reached an agreement with SAY-GIN Ozel Egtim Yayincilik Ticaret Hizmetleri (SAY-GIN) for distribution of its ActiPatch and Allay products in Turkey.

9 Feb 2010

Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiency

Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.

9 Feb 2010

Synovis Life Technologies' Flow Coupler receives FDA marketing approval

Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company’s well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.

9 Feb 2010

AnaptysBio, Merck announce strategic collaboration to develop novel antibody therapeutics

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a strategic collaboration with Merck, through an affiliate, to develop novel antibody therapeutics to a specified disease target.

8 Feb 2010

AmerisourceBergen offers rapid implementation methodology for meaningful use of EHRs

AmerisourceBergen announced a unique offering designed to help hospitals and health systems achieve meaningful use readiness for electronic health records (EHR), regardless of the technology they are using.

8 Feb 2010

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

Stereotaxis today announced the installation of its first Stereotaxis Magnetic Navigation System in Taiwan at Cheng-Hsin General Hospital (CHMC) located in Taipei. CHMC hosted a Grand Opening event on January 26 that received wide coverage throughout the area and, to date, ten procedures have been successfully performed using Stereotaxis at the hospital.

8 Feb 2010

Big Ow awareness campaign

When it comes to symptoms of menopause like hot flashes, weight gain or trouble sleeping, chances are most women wouldn't hesitate to speak to their doctor. But there is another common - and equally distressing - effect of menopause that many women just keep to themselves. The Big Ow, also known as vaginal atrophy, will affect as many as two million Canadian women in the next 10 years - but most are too shy or embarrassed to talk about it, even with their doctor.

8 Feb 2010

LPC Pharma Group outsources pharmacovigilance/drug safety operations to APCER Pharma

APCER Pharma announced that LPC Pharma Group is outsourcing its pharmacovigilance/drug safety operations to APCER.

8 Feb 2010

Innovative health text messaging applications launched

Health Txts assists people in changing unhealthy behaviors by sending text messages that encourage specific self-improvement goals at the times and in the places people need it most. For example, someone may receive a message at 10pm saying "only floss the teeth you want to keep." Health Txts can be used for nearly any self-improvement goal such as reducing drinking, eating healthier or even becoming more environmentally conscious.

6 Feb 2010

Oral care with ionic toothbrush

Smile and the world smiles with you. Well, the folks at Global Ionics LLC, makers of the Ionic ProClean toothbrush, are smiling a lot these days; especially since receiving the impressive results of a clinical evaluation conducted by THE DENTAL ADVISOR. In a clinical assessment, the Ionic ProClean was evaluated by a team of dental professionals and 107 patients in over 11,100 uses. The results? Dental professionals reported that they observed less tartar buildup and gingivitis, and believed the toothbrush contributed to good oral hygiene: earning the Ionic ProClean a 4+ rating from THE DENTAL ADVISOR.

6 Feb 2010

EndoSheath Systems advantageous over germicidal immersion in preventing flexible ENT scope contamination

Results of a clinical study presented Thursday, Feb. 4 at the annual Triological Society meetings in Orlando, Fla., suggest a sterile barrier sheath system has distinct advantages over germicidal immersion processes used to prevent contamination of fiberoptic nasopharyngolaryngoscopes (flexible ENT scopes). Flexible ENT scopes are used by otolaryngologists to examine the nose and throat area for various disorders such as dysphagia, reflux disease, snoring, and chronic sinusitis.

6 Feb 2010

Artificial pancreas can help manage diabetes in kids overnight

In a landmark study in children and teenagers with type 1 diabetes, JDRF-funded researchers at the University of Cambridge showed that using a first-generation artificial pancreas system overnight can lower the risk of low blood sugar emergencies while sleeping, and at the same time improve diabetes control.

6 Feb 2010

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

MDS Nordion, a global leader in providing products and services for medical imaging and radiotherapeutics, today announced that two of the largest health insurers in the United States have recently approved coverage of radioembolization to treat unresectable liver cancer, which includes the use of MDS Nordion's TheraSphere(R) treatment. The two insurance companies and their affiliates together serve more than one-quarter of Americans and do business in all 50 states.

6 Feb 2010

Over 12,000 courses of lung cancer treatment completed with Accuray's CyberKnife radiosurgery

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009.

6 Feb 2010

Sunridge International extends distribution contract with Beijing Vision World Trading

Sunridge International announced today that they have extended the exclusive distribution agreement with Beijing Vision World Trading Co., Ltd. for an additional 4 years.

6 Feb 2010

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

Health Discovery Corporation announced today that the Company has entered into an exclusive agreement with the Pancreas, Biliary and Liver Surgery Center of New York at Saint Vincent Catholic Medical Centers in New York City to develop new molecular diagnostic tests for the early detection of pancreatic cancer. The Pancreas, Biliary and Liver Surgery Center is under the leadership of Drs. Michael Wayne, Franklin Kassim and Avram Cooperman.

6 Feb 2010

Device / Technology News

Phase 1 trial of Cerus' INTERCEPT red blood system meets primary endpoint

BD recalls certain lots of BD Q-Syte Luer Access Devices and BD Nexiva Closed IV Catheter Systems

Emerging Healthcare Solutions issues Term Sheet review to ThromboVision

Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovarian cancer

BioElectronics and SAY-GIN sign agreement to sell ActiPatch and Allay products in Turkey

Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiency

Synovis Life Technologies' Flow Coupler receives FDA marketing approval

AnaptysBio, Merck announce strategic collaboration to develop novel antibody therapeutics

AmerisourceBergen offers rapid implementation methodology for meaningful use of EHRs

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

Big Ow awareness campaign

LPC Pharma Group outsources pharmacovigilance/drug safety operations to APCER Pharma

Innovative health text messaging applications launched

Oral care with ionic toothbrush

EndoSheath Systems advantageous over germicidal immersion in preventing flexible ENT scope contamination

Artificial pancreas can help manage diabetes in kids overnight

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

Over 12,000 courses of lung cancer treatment completed with Accuray's CyberKnife radiosurgery

Sunridge International extends distribution contract with Beijing Vision World Trading

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News